Company

ESSA Pharma Inc.

Headquarters: Vancouver, BC, Canada

Employees: 25

CEO: Dr. David Ross Parkinson M.D.

NASDAQ: EPIX -4.84%

Market Cap

$222.7 Million

USD as of July 1, 2024

Market Cap History

ESSA Pharma Inc. market capitalization over time

Evolution of ESSA Pharma Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of ESSA Pharma Inc.

Detailed Description

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

ESSA Pharma Inc. has the following listings and related stock indices.


Stock: NASDAQ: EPIX wb_incandescent

Stock: FSX: E031 wb_incandescent

Details

Headquarters:

999 West Broadway

Suite 720

Vancouver, BC V5Z 1K5

Canada

Phone: 778 331 0962